Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
12.79
+0.33 (2.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
DAWN Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1,290 | 1,271 | 1,583 | 1,044 | - | - |
| Market Cap Growth | 30.33% | -19.71% | 51.68% | - | - | - |
| Enterprise Value | 734 | 866 | 1,209 | 747 | - | - |
| Last Close Price | 12.79 | 14.60 | 21.52 | 16.85 | - | - |
| PB Ratio | 2.32 | 3.67 | 4.77 | 3.71 | - | - |
| P/TBV Ratio | 2.58 | 3.67 | 4.77 | 3.71 | - | - |
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | - |
| Quick Ratio | 14.27 | 12.42 | 20.60 | 32.84 | 21.91 | 13.52 |
| Current Ratio | 14.62 | 12.72 | 20.94 | 33.43 | 22.58 | 13.53 |
| Return on Equity (ROE) | -17.84% | -55.68% | -46.37% | -44.83% | -127.49% | - |
| Return on Assets (ROA) | -25.43% | -35.52% | -28.74% | -27.10% | -23.60% | - |
| Return on Capital (ROIC) | -27.22% | -37.89% | -29.90% | -27.96% | -24.90% | - |
| Earnings Yield | -6.54% | -14.87% | -8.98% | -6.77% | - | - |
| FCF Yield | -7.00% | -11.57% | -6.94% | -4.65% | - | - |
| Buyback Yield / Dilution | -17.15% | -21.85% | -77.13% | -568.42% | 6.67% | - |
| Total Shareholder Return | -17.15% | -21.85% | -77.13% | -568.42% | 6.67% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.